Government asks drug regulator to 'understand the data' behind Oxford's Covid vaccine amid fears trial data was based on 'shaky science' because 'NO ONE who got the dose that had 90% success rate was aged over 55'

MHRA will assess the Oxford/AstraZeneca vaccine as soon as it gets full data
Race is now on between Oxford and Pfizer for first approval in the UK
Same process began on Pfizer's '95% effective' jab last week after trial results

Submitted by unewsy on Fri, 11/27/2020 - 11:36

Tags: